Skip to content
MedsAcross

Medicine

Ellence 50 mg/25 mL injection

Epirubicin · Intravenous · Pharmacia & Upjohn
Available on requestPrescription onlyUS FDA Cold chain

Ellence 50 mg/25 mL injection is a prescription medicine containing Epirubicin for intravenous use, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store refrigerated between 2°C and 8°C (36°F and 46°F). Do not freeze. Storage…

Key facts

Active ingredient (INN)
Epirubicin
Brand
Ellence
Strength
50 mg/25 mL
Dosage form
Injection
Route
Intravenous
Packs
1 vial of 25 mL
Marketing authorisation holder
Pharmacia & Upjohn
Manufacturer
Pharmacia & Upjohn
Origin register
US FDA, United States
Storage
Store refrigerated between 2°C and 8°C (36°F and 46°F). Do not freeze. Storage of the solution for injection at refrigerated conditions can result in the formation of a gelled product. This gelled product will return to a slightly viscous to mobile solution after 2 to a maximum of 4 hours equilibration at controlled room temperature (15–25°C).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01DB03 Epirubicin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 September 1999
Identifiers
RxCUI 1732182, 1732183, 1732186 +1DailyMed set ID 0a03c798-a652-4895-b29c-3b521a89ba42NDC 0009-5091Application NDA050778

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, single-dose in 1 carton / 25 mL in 1 vial, single-dose0009-5091-25Pharmacia & Upjohn24 March 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 September 1999Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Epirubicin

Clinical summary

Epirubicin is an anthracycline topoisomerase inhibitor indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer. It is available as injection for intravenous use. MedsAcross supplies Epirubicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Epirubicin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ellence 50 mg/25 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.